MktsMarkets

PDS Biotechnology Corporation
NASDAQ: PDSBKey statistics
PDSB News
Stories mentioning PDSB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 3,457 | 4,576 | 4,213 | 5,831 | 6,804 | 4,528 | ||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 6,521 | 8,140 | 7,623 | 9,106 | 10,179 | 8,684 | ||
| Operating Income (Loss) | (6,521) | (8,140) | (7,623) | (9,106) | (10,179) | (8,684) | ||
| Interest Income | 187.00 | 281.00 | 334.00 | 378.00 | 667.00 | 675.00 | ||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (7,349) | (9,009) | (9,434) | (9,659) | (10,727) | (9,197) | ||
| Tax Provision | 0.00 | 0.00 | 0.00 | (1,170) | 0.00 | (869.00) | ||
| Net Income (Loss) | (7,349) | (7,563) | (9,009) | (9,434) | (8,489) | (7,952) | (10,727) | (8,328) |
| Earnings Per Share (Basic) | (0.13) | (0.16) | (0.19) | (0.21) | (0.21) | (0.22) | (0.29) | (0.23) |
| Earnings Per Share (Diluted) | (0.13) | (0.16) | (0.19) | (0.21) | (0.21) | (0.22) | (0.29) | (0.23) |
| Weighted Average Shares Outstanding (Basic) | 55,496 | 46,384 | 46,870 | 45,903 | 40,521 | 36,453 | 36,807 | 36,694 |
| Weighted Average Shares Outstanding (Diluted) | 55,496 | 46,384 | 46,870 | 45,903 | 40,521 | 36,453 | 36,807 | 36,694 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PDSB
PDS Biotechnology Corporation (NASDAQ: PDSB) is a stock listed on the Nasdaq Stock Market under the ticker symbol PDSB. It last traded at $0.9900 (Nov 10, 2026, 3:50 PM ET), down 7.9% on the day. That gives PDS Biotechnology a market capitalisation of $113.9M.
Over the past 52 weeks PDSB has traded between $0.2000 and $1.79.
For the quarter ended Mar 31, 2026 it reported a net loss of $7.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$7.3M |
| Dec 31, 2025 | — | -$7.6M |
| Sep 30, 2025 | — | -$9.0M |
| Jun 30, 2025 | — | -$9.4M |
From PDS Biotechnology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…